THE USE OF dynamic contrast‐enhanced magnetic resonance imaging (DCE‐MRI) has shown potential for obtaining predictive and prognostic biomarkers in rectal cancer. This method has enabled estimation of parameters with the ability to predict histopathologic treatment outcome to preoperative chemoradiotherapy[1](#jmri26740-bib-0001){ref-type="ref"} and distinguish between tumor differentiation grades.[2](#jmri26740-bib-0002){ref-type="ref"} These results indicate that DCE‐MRI may be a tool to enable further treatment individualization in rectal cancer at the time of diagnosis.

DCE‐MRI aims at estimating capillary permeability by measuring the rate of extravasation of an intravenously injected gadolinium‐based contrast agent (GBCA). However, for patients with impaired kidney function there are contraindications to these types of contrast agents, and in addition there are some concerns regarding the safety and long‐term retention of GBCA.[3](#jmri26740-bib-0003){ref-type="ref"}, [4](#jmri26740-bib-0004){ref-type="ref"} This encourages investigation of alternative noncontrast agent‐based approaches for obtaining functional MRI‐derived biomarkers.

In recent years the concept of intravoxel incoherent motion (IVIM) imaging has received growing attention. IVIM is an expansion of conventional diffusion‐weighted imaging (DWI) whereby intravascular water reflecting microcirculatory properties can be separated from extravascular water due to different diffusion properties.[5](#jmri26740-bib-0005){ref-type="ref"} IVIM‐based DWI has shown promise as a completely noninvasive approach for obtaining perfusion‐related information[6](#jmri26740-bib-0006){ref-type="ref"} and is thus clearly an attractive technique both in terms of reduced cost as well as patient safety compared with methods requiring contrast agent injections.

The relationship between IVIM‐derived perfusion metrics and the more conventional contrast agent (CA)‐based methods for measuring perfusion‐related parameters with MRI remains unclear. According to a recent review by Federau,[7](#jmri26740-bib-0007){ref-type="ref"} the strongest correlation between IVIM‐ and CA‐based perfusion metrics in human studies has been reported in brain tumors using the dynamic susceptibility contrast (DSC)‐MRI method. DSC‐MRI is a CA‐based method whereby the T~2~\*‐ (susceptibility) effect, rather than the T~1~‐effect of the CA, is utilized to measure perfusion‐related metrics. DSC‐MRI has mainly been used in the brain due to dominant T~2~\*‐effects in regions with an intact blood--brain barrier,[8](#jmri26740-bib-0008){ref-type="ref"} but has recently also shown utility in staging of rectal cancer.[9](#jmri26740-bib-0009){ref-type="ref"} Specifically addressing brain tumors, Bisdas et al[10](#jmri26740-bib-0010){ref-type="ref"} found good correlation between perfusion measured by DSC‐MRI and IVIM‐derived metrics but generally poorer correlation between DCE‐MRI‐derived metrics and IVIM. Also, for applications outside the central nervous system (CNS), the correlations between IVIM and DCE‐MRI‐derived metrics are generally unclear.[11](#jmri26740-bib-0011){ref-type="ref"}, [12](#jmri26740-bib-0012){ref-type="ref"} Although some DCE‐MRI models can be used to estimate perfusion and tissue blood volume, most DCE‐MRI studies focus on measurement of permeability‐related metrics and their correlation with IVIM‐related parameters may be less obvious. Further, DCE‐MRI is generally hampered by poor reproducibility and lack of standardization with respect to the choice of kinetic model and acquisition protocol.[13](#jmri26740-bib-0013){ref-type="ref"}

The purpose of the present work was to examine the associations between perfusion‐related parameters measured by IVIM with those obtained from DSC‐ and DCE‐MRI in patients with rectal cancer. By using a multiecho dynamic contrast‐based sequence, both DSC‐ and DCE‐derived metrics were obtained in a single acquisition, thereby potentially providing more accurate comparisons between the different methods.

Materials and Methods {#jmri26740-sec-0013}
=====================

*Patients* {#jmri26740-sec-0014}
----------

This investigation was part of a prospective biomarker study enrolling 192 patients with suspected rectal cancer between October 2013 and December 2017. Excluding cases without histologically confirmed rectal cancer (*n* = 19) or with study withdrawal (*n* = 4), nonconsistent MRI sequence due to set‐up of experiment (*n* = 23), poor quality of dynamic images (*n* = 20), difficulties in coregistration due to bowel movement or tumor volume \<5 cm^3^ (*n* = 6), and other incidental difficulties encountered during the clinical MRI acquisition (eg, patients medically ineligible for or refusing contrast administration, software updates disarranging the timing of contrast administration) (*n* = 26), a total of 94 patients were included in this report. The MRI was acquired at baseline before any treatment had been initiated.

The study was performed in accordance with the Helsinki Declaration and written informed consent was obtained from all patients. Approval was obtained from the Institutional Review Board and the Regional Committee for Medical and Health Research Ethics.

*MRI* {#jmri26740-sec-0015}
-----

MRI was performed with a Philips Achieva 1.5T system (Philips Healthcare, Best, The Netherlands). To reduce bowel movement, patients were given glucagon (1 mg/ml, 1 mL intramuscularly) and Buscopan (10 mg/ml, 1 mL intravenously) before scanning, and an equivalent dose of Buscopan before commencement of the dynamic acquisition.

The patients underwent MRI according to clinical procedure, including a high‐resolution T~2~‐weighted sequence perpendicular to the tumor axis used for tumor delineation. In addition, the patients underwent a multiecho dynamic contrast‐based MRI with GBCA injection and an extended DWI sequence.

DWI was obtained with seven b‐values, b = 0, 25, 50, 100, 500, 1000, 1300 s/mm^2^, echo time (TE) = 75 msec, repetition time (TR) = 3 sec, and 6 averages. The acquired matrix size was 80 × 60 over a 160 × 160 mm^2^ field of view and a 4 mm slice thickness, giving a spatial resolution of 2.00 × 2.67 × 4.00 mm^3^.

The dynamic sequence was obtained as a 3D multishot echo planar imaging sequence with three echoes, TE = 4.6, 13.9, 23.2 msec, TR = 39 msec, flip angle 39°, time resolution that varied between 1.9 and 2.5 sec, with \~60 repetitions. The acquired matrix size was 92 × 90 over a 180 × 180 mm^2^ field of view and a 10 mm slice thickness, giving a spatial resolution of 1.96 × 2.00 × 10 mm^3^. A dose of 0.2 mL/kg body weight of GBCA (Dotarem, 279.3 mg/mL, Guerbet Roissy, France) was injected as a bolus directly followed by a 20‐mL saline solution.

*Image Postprocessing* {#jmri26740-sec-0016}
----------------------

The acquired multiecho data was used to extract two dynamic time series by least‐square fitting from the equation:$$S\left( {t,{TE_{n}}} \right) = M_{0}\left( t \right)e^{- TE_{n}/T_{2}^{*}{(t)}}$$where S(t, TE~n~) is the acquired signal, *n* is the echo number, and M~0~(t) is the T~1~‐weighted signal corrected for effects from T~2~\*‐relaxation. In addition to T~1~‐weighted DCE analysis, this fit also allowed estimation of the dynamic R~2~\*(t) = 1/T~2~\*(t) signal used for DSC analysis.

### *DSC‐MRI* {#jmri26740-sec-0017}

Assuming a linear relationship between the change in R~2~\*(t) and CA concentration to obtain semiquantitative parameters, the blood flow (*BF*) was calculated using the established tracer kinetic model for DSC‐MRI[14](#jmri26740-bib-0014){ref-type="ref"}:$$C_{t}\left( t \right) = \mathit{\beta f}\int_{0}^{t}\mathit{AIF}\left( \tau \right)\ R\left( {t - \tau} \right)\ \mathit{d\tau}$$where C~t~(t)is the CA concentration in tissue, AIF(t) is the arterial input function (CA concentration in a feeding artery), R(t) is the residue function, and β is an unknown scaling factor. *f* is the fractional flow value and is related to tissue blood flow (perfusion, *BF*) according to:$$\mathit{BF} = f\frac{k_{h}}{\rho}$$where ρ is the tissue density (g/ml) and k~h~ is the hematocrit scaling factor between large and small blood vessels,[15](#jmri26740-bib-0015){ref-type="ref"} and was assumed to be constant. Since the values of β and k~h~ are not known, the resulting *BF* values should be regarded as relative perfusion estimates.

The AIF was obtained individually from a nearby artery using an automatic cluster‐algorithm.[16](#jmri26740-bib-0016){ref-type="ref"} The convolution integral was solved using circular singular value decomposition.[17](#jmri26740-bib-0017){ref-type="ref"} Area under curve (AUC) for 30 and 60 seconds was calculated as an approximation of tissue blood volume as:$$\mathit{AUC} = \frac{\int\limits_{0}^{t}C_{t}\left( \tau \right)\mathit{d\tau}}{\int\limits_{0}^{t}\mathit{AIF}\left( \tau \right)\mathit{d\tau}}$$where the lower integration limit was set at bolus arrival time and the upper integration limit was set at 30 and 60 seconds, respectively.

### *DCE‐MRI* {#jmri26740-sec-0018}

The M~0~(t) signal was then used to estimate the CA concentration using the signal equation for a spoiled gradient echo (SPGR) sequence without T~2~\* relaxation contribution:$$S_{\textit{SPGR}}\left( t \right) = M_{0}\left( t \right)\frac{\sin\alpha\left( {1 - e^{- \frac{\mathit{TR}}{T_{1}{(t)}}}\ } \right)}{1 - e^{- \frac{\mathit{TR}}{T_{1}{(t)}}}\cos\alpha\ }$$

As for the DSC analysis, a linear relationship was assumed between the change in R~1~ = 1/T~1~ and CA concentration, and an average precontrast T~1~‐value measured from six patients was used (1350 msec in tissue).[9](#jmri26740-bib-0009){ref-type="ref"}

The extended Tofts (ET) model[18](#jmri26740-bib-0018){ref-type="ref"} was fitted to the data with the equation:$$C_{t}\left( t \right) = v_{p}\mathit{AIF}\left( t \right) + K^{\textit{trans}}\ \int_{0}^{t}e^{- \tau k_{\mathit{ep}}}\mathit{AIF}\left( \tau \right)\mathit{d\tau}$$where *K* ^*trans*^ is the transfer constant between blood plasma and the interstitial space, *k* ~*ep*~ the rate constant, and *v* ~*p*~ the blood plasma volume. These parameters relate to the extracellular, extravascular space, *v* ~*e*~, as *v* ~*e*~ = *K* ^*trans*^/*k* ~*ep*~. The same individual AIF as for the DSC analysis was used.

The DCE and DSC‐MRI analyses were done in nordicICE (NordicNeuroLab, Bergen, Norway).

### *IVIM* {#jmri26740-sec-0019}

The DWI signal was fitted to the equation:$$\frac{S\left( b \right)}{S_{0}} = fe^{- bD^{*}} + \left( {1 - f} \right)e^{- \mathit{bD}}$$where *f* is the perfusion fraction, *D\** is the pseudodiffusion coefficient, and *D* is the diffusion coefficient. We also calculated the product of the perfusion fraction and pseudodiffusion, *f* × *D\**. The fit was done in MatLab (R2015a, MathWorks, Natick, MA) using a Levenberg--Marquardt algorithm. To check for consistency of the results, the exponential fit was performed both with and without b = 1300 s/mm^2^.

Tumor delineation was done by two radiologists with 14 and 7 years of experience on T~2~‐weighted images, with the DWI serving as extra guidance. The resultant tumor regions were then semiautomatically coregistered to the other image sequences for optimal fit, also done in nordicICE.

*Immunohistochemistry* {#jmri26740-sec-0020}
----------------------

After surgery, 17 tumors were randomly selected for immunohistochemistry (IHC). Formalin‐fixed paraffin‐embedded tissue sections (4 μm thick) were deparaffinized and hydrated followed by heat‐induced epitope retrieval (20 min at 97°C, 3‐in‐1 procedure) in Dako (Carpinteria, CA) PT‐link with target retrieval solution with high pH (code K8004). Incubation time with the primary antibody was 30 minutes and with the secondary antibody/HRP it was 20 minutes. Counterstaining was performed with Hagens hematoxylin (5 min, diluted 1:4). Staining with CD34 (mouse monoclonal antibody, clone QBEnd/10, Nordic BioSite, Sweden) was performed with the Autostainer Link 48 (Dako) using the Dako Envision Flex Code 8000 visualization kit. Appropriate controls were included and showed satisfactory results. The slides were scanned using the Aperio Scanscope AT using a 20×/0.75 objective with a 0.50 μm/pixel resolution. Microvessel density (MVD) and average vessel size were extracted from the scanned slides by an automated and adapted MatLab script.[19](#jmri26740-bib-0019){ref-type="ref"}

*Statistical Analysis* {#jmri26740-sec-0021}
----------------------

Consistency in tumor delineation and reproducibility of the individual parameters for the two radiologists was evaluated with intraclass correlation tests. Correlations between parameters were investigated using Spearman rank correlation test. Results were deemed statistically significant if *P* \< 0.01, to lower risk of false positives due to multiple testing. All statistical procedures were done in SPSS (v. 25, IBM, Armonk, NY).

Results {#jmri26740-sec-0022}
=======

Patient demographics are given in Table [1](#jmri26740-tbl-0001){ref-type="table"}. Estimated kinetic parameters obtained from the tumor volumes defined by the two radiologists were highly correlated (Table [2](#jmri26740-tbl-0002){ref-type="table"}), and therefore only one set of parameter results is reported. The IVIM parameters showed only linear shifts towards higher *D\**, and lower *f* and *D*, when omitting b = 1300 s/mm^2^ compared with using all seven b‐values. The correlation between the set of IVIM parameters (*f, D, D\**) estimated from six and seven b‐values was high (\>0.90) and the associations with other parameters (from DCE‐ and DSC‐MRI) showed the same trends. The results reported in the following are from all seven b‐values.

###### 

Patient Demographics for the Study

  -------------------- ----------
  Number of patients   94
  Females              33 (35%)
  Males                61 (65%)
  Age (median)         65 years
  Disease stage        
  T2                   14 (15%)
  T3                   46 (49%)
  T4                   34 (36%)
  N0                   39 (42%)
  N1                   33 (35%)
  N2                   22 (23%)
  M0                   71 (76%)
  M1                   23 (24%)
  -------------------- ----------

###### 

Estimated values

                                     Median values (25th ‐ 75th percentile)   ICC (confidence interval)
  --------------------------------- ---------------------------------------- ---------------------------
  IVIM                                                                       
  *f* (fraction)                               0.33 (0.30--0.37)                  0.96 (0.95--0.98)
  *D* ^*\**^ (10^‐3^ mm^2^/s)                 12.11 (9.87--14.35)                 0.97 (0.95--0.98)
  *f x D* ^*\**^ (10^‐3^ mm^2^/s)              3.75 (2.93--4.57)                  0.98 (0.97--0.99)
  *D* (10^‐3^ mm^2^/s)                         0.60 (0.50--0.71)                  0.98 (0.96--0.98)
  DSC                                                                        
  *BF* (ml/min/100g)                         107.06 (78.32--135.80)               0.97 (0.95--0.98)
  *AUC* ~*30*~ (a. u.)                         0.12 (0.03--0.22)                  0.96 (0.93--0.97)
  *AUC* ~*60*~ (a. u.)                         0.55 (0.31--0.80)                  0.93 (0.90--0.96)
  DCE                                                                        
  *K* ^*trans*^ (min^‐1^)                      0.04 (0.02--0.06)                  0.96 (0.94--0.97)
  *k* ~*ep*~ (min^‐1^)                         0.24 (0.11--0.38)                  0.96 (0.94--0.97)
  *v* ~*p*~ (%)                                0.11 (0.05--0.17)                  0.96 (0.94--0.98)
  *v* ~*e*~ (%)                               10.58 (5.68--15.49)                 0.59 (0.38--0.73)

Median values based on tumor delineations from one radiologist and intraclass correlation coefficients (ICC) between the two radiologists. *f* = perfusion fraction, *D* ^*\**^ = pseudodiffusion coefficient, *D* = diffusion coefficient, *BF* = relative blood flow, *AUC* ~*30*~/*AUC* ~*60*~ = area under curve for 30 and 60 seconds, respectively, after bolus arrival (*a. u*. = arbitrary units), *K* ^*trans*^ = transfer constant between blood plasma and the interstitial space, *k* ~*ep*~ = rate constant, *v* ~*p*~ = blood plasma volume, *v* ~*e*~ = extracellular, extravascular space.

Median values and interquartile ranges for all calculated parameters are given in Table [2](#jmri26740-tbl-0002){ref-type="table"} and examples of parameter images overlaid on T~2~‐weighted images are shown in Fig. [1](#jmri26740-fig-0001){ref-type="fig"}. Spearman\'s rank correlation coefficients (r~s~) and *P*‐values for comparisons between parameters are given in Tables [3](#jmri26740-tbl-0003){ref-type="table"}, [4](#jmri26740-tbl-0004){ref-type="table"}, [5](#jmri26740-tbl-0005){ref-type="table"}, and scatterplots of the most significant findings are presented in Fig. [2](#jmri26740-fig-0002){ref-type="fig"}. From IVIM, the pseudodiffusion coefficient *D\** was correlated with *BF* from the DSC‐analysis (r~s~ = 0.47; *P* \< 0.001) (Table [3](#jmri26740-tbl-0003){ref-type="table"}), and the perfusion fraction *f* showed a negative correlation with *k* ~*ep*~ from the DCE‐analysis (r~s~ = --0.31; *P* \< 0.002) (Table [4](#jmri26740-tbl-0004){ref-type="table"}). The comparison of parameters from DSC‐MRI and DCE‐MRI (Table [5](#jmri26740-tbl-0005){ref-type="table"}) revealed a correlation between *BF* and *K* ^*trans*^ (r~s~ = 0.29; *P* = 0.004), and between *BF* and *v* ~*p*~ (r~s~ = 0.44; *P* \< 0.001). Both AUC~30~ and AUC~60~ correlated with *v* ~*e*~ (r~s~ = 0.34; *P* = 0.001, and r~s~ = 0.45; *P* \< 0.001, respectively) and, in the case of AUC~60~, also a negative correlation with *k* ~*ep*~ (r~s~ = --0.45; *P* \< 0.001). Theoretically, *BF* and *K* ^*trans*^ are only associated in a flow limited regime[20](#jmri26740-bib-0020){ref-type="ref"} (low perfusion). The correlation between *BF* and *K* ^*trans*^ was stronger (r~s~ = 0.62, *P* \< 0.001) when analyzing tumors with *BF* \< 100 ml/min/100 g, corresponding to the lower half of the population (*n* = 47) (Fig. [3](#jmri26740-fig-0003){ref-type="fig"}). When analyzing the other half of the population (*BF* \> 100 ml/min/100 g), no correlation between these parameters was found (r~s~ = --0.06, *P* = 0.68).

![Examples of parametric images from a male patient with a T3 rectal tumor (parametric images of the tumor area shown as color overlays on T~2~‐weighted images), **(a)** *f*, **(b)** *D\**, **(c)** *D*, **(d)** *BF*, **(e)** AUC~30~, **(f)** AUC~60~, **(g)** *K* ^*trans*^, **(h)** *k* ~*ep*~, **(i)** *v* ~*p*~, and **(j)** *v* ~*e*~.](JMRI-50-1114-g001){#jmri26740-fig-0001}

###### 

Correlations between IVIM‐ and DSC‐MRI

                           *BF*          *AUC* ~*30*~    *AUC* ~*60*~
  ---------------- -------------------- --------------- --------------
  *f*                 --0.03 (0.80)      --0.03 (0.79)   0.12 (0.26)
  *D* ^*\**^        **0.47 (\<0.001)**    0.15 (0.15)    0.22 (0.03)
  *f x D* ^*\**^    **0.38 (\<0.001)**    0.09 (0.41)    0.23 (0.03)
  *D*                 --0.23 (0.03)       0.05 (0.61)    ‐0.07 (0.52)

Spearman\'s Rank Correlation Coefficients r~s~ (P‐values in parenthesis)

###### 

Correlations between IVIM‐ and DCE‐MRI

                      *K* ^*trans*^          *k* ~*ep*~         *v* ~*p*~       *v* ~*e*~
  ---------------- -------------------- -------------------- --------------- ---------------
  *f*                 --0.22 (0.03)      **--0.31 (0.002)**   --0.17 (0.10)    0.23 (0.03)
  *D* ^*\**^          --0.18 (0.09)         0.06 (0.54)        0.12 (0.27)    --0.16 (0.13)
  *f x D* ^*\**^    **--0.28 (0.007)**     --0.10 (0.32)       0.01 (0.97)    --0.01 (0.98)
  *D*                  0.03 (0.81)         --0.11 (0.28)      --0.12 (0.25)    0.13 (0.19)

Spearman\'s Rank Correlation Coefficients r~s~ (P‐values in parenthesis)

###### 

Correlations between DSC‐ and DCE‐MRI

                   *K* ^*trans*^          *k* ~*ep*~            *v* ~*p*~            *v* ~*e*~
  -------------- ------------------ ---------------------- -------------------- --------------------
  *BF*            **0.29 (0.004)**       0.05 (0.67)        **0.44 (\<0.001)**      0.10 (0.35)
  *AUC* ~*30*~      0.14 (0.17)         --0.23 (0.03)          0.08 (0.44)        **0.34 (0.001)**
  *AUC* ~*60*~      0.15 (0.14)      **--0.45 (\<0.001)**      0.08 (0.47)       **0.45 (\<0.001)**

Spearman\'s Rank Correlation Coefficients r~s~ (P‐values in parenthesis)

![Scatterplot with the least square regression line of the most prominent results, **(a)** *BF* vs. *D\**, **(b)** *f* vs. *k* ~*ep*~, **(c)** *BF* vs. *K* ^*trans*^, **(d)** *BF* vs. *v* ~*p*~, **(e)** AUC~60~ vs. *k* ~*ep*~, **(f)** AUC~60~ vs. *v* ~*e*~. Spearman\'s rank correlation coefficients (r~s~) and *P*‐values are indicated.](JMRI-50-1114-g002){#jmri26740-fig-0002}

![Scatterplot showing the correlation between *BF* and *K* ^*trans*^ separated in populations with **(a)** low (\<100) and **(b)** high (\>100 ml/min/100 g) *BF*. Spearman\'s rank correlation coefficients (r~s~) and *P*‐values are indicated.](JMRI-50-1114-g003){#jmri26740-fig-0003}

Of the 17 tumor specimens analyzed by IHC, 12 had a full set of MRI parameters for correlation analysis. There was no correlation between MVD or vessel size and any MRI‐derived parameters. However, when looking at tumors with *BF* \> 100 ml/min/100 g (*n* = 10), we observed a negative correlation between vessel size and *K* ^*trans*^ (r~s~ = --0.82, *P* = 0.004) (Fig. [4](#jmri26740-fig-0004){ref-type="fig"}).

![Scatterplot showing the correlation between vessel size quantified from CD34‐based immunohistochemistry of excised tumors and *K* ^*trans*^ from DCE‐MRI. Spearman\'s rank correlation coefficient (r~s~) and *P*‐values are indicated.](JMRI-50-1114-g004){#jmri26740-fig-0004}

Discussion {#jmri26740-sec-0023}
==========

A main result from this study of 94 rectal tumors is the correlation between *D\** from IVIM imaging and *BF* from DSC‐MRI. This is in line with the findings of Bisdas et al,[10](#jmri26740-bib-0010){ref-type="ref"} where a strong correlation between these parameters was found in glioblastomas. To our knowledge, this relationship has so far not been examined outside the CNS. The validity of measuring perfusion with the IVIM‐method has been questioned,[21](#jmri26740-bib-0021){ref-type="ref"} and we show here that there at least exists a linear relationship between the pseudodiffusion coefficient and perfusion estimated by contrast‐based MRI.

Previous studies have examined the link between IVIM imaging and DCE‐MRI, with varying results,[10](#jmri26740-bib-0010){ref-type="ref"}, [11](#jmri26740-bib-0011){ref-type="ref"}, [22](#jmri26740-bib-0022){ref-type="ref"} possibly reflecting the numerous qualitative and quantitative methods used to analyze DCE data. In addition, the interpretation of the parameters from DCE‐MRI can vary depending on the underlying biology. In particular, *K* ^*trans*^ will reflect tissue blood flow if tissue perfusion is low relative to the permeability surface area product (flow‐limited regime), and conversely will reflect permeability if tissue perfusion is high relative to the permeability surface area product (permeability‐limited regime).[20](#jmri26740-bib-0020){ref-type="ref"} In the limiting condition of a pure permeability‐limited regime, perfusion and permeability are therefore expected to be uncorrelated. The results from our data suggest that blood flow in this population of rectal tumors spans both these regimes, where low *BF* in tumors was strongly correlated with *K* ^*trans*^, and high tumor *BF* was not correlated, suggesting that the heterogeneity of rectal cancers makes it challenging to interpret results in studies focusing only on DCE‐MRI. There was no significant correlation between MVD and *K* ^*trans*^, in line with a report by Kim et al,[23](#jmri26740-bib-0023){ref-type="ref"} but we observed a strong negative correlation between *K* ^*trans*^ and vessel size in tumors with high perfusion. The cases for this analysis were in the high *BF* group where *K* ^*trans*^ is only expected to be dependent on permeability and surface area of the vessels.[18](#jmri26740-bib-0018){ref-type="ref"} The higher leakage from smaller vessels may be explained by their larger ratio of circumference to cross‐section measures compared with larger vessels, and hence larger surface area per unit blood volume. No other MRI‐derived parameters were correlated with MVD or vessel size, which may reflect that MRI parameters in general are measured in in vivo functional tissue, and therefore will not be adequately represented in ex vivo resected tissue.

We further observed a correlation between *BF* and *v* ~*p*~. This is not surprising, since an increase in plasma volume would lead to a similar increase in tissue perfusion for constant blood supply. It should be noted that the ET model used to estimate *v* ~*p*~ and permeability is only strictly valid in the limiting case of very high tissue blood flow (negligible mean capillary transit time, MTT).[20](#jmri26740-bib-0020){ref-type="ref"} Since blood flow estimates are independent of MTT, any correlations between *BF* and DCE‐parameters derived using the ET model may be biased by local variations in tissue MTT. In particular, the measured parameter *v* ~*p*~ may therefore reflect a mixture of blood volume and plasma flow. Using a more complex kinetic model, like the two‐compartment exchange model, might account for MTT variations and also provide direct estimates of tissue perfusion from the DCE data,[20](#jmri26740-bib-0020){ref-type="ref"} but we question whether our data supports the use of an even more complex model.

In some reports about the relationship between IVIM‐ and DCE‐MRI parameters,[24](#jmri26740-bib-0024){ref-type="ref"}, [25](#jmri26740-bib-0025){ref-type="ref"} the focus has been on the correlation between the perfusion fraction *f* from IVIM and blood volume from DCE, as this is the expected theoretical relationship according to one of the original works of Le Bihan and Turner.[26](#jmri26740-bib-0026){ref-type="ref"} The hypothesis that *v* ~*p*~ derived from the ET model likely reflects a combination of both blood flow and blood volume could be a possible reason for the absence of this correlation between *f* and *v* ~*p*~ in our data. In the model‐free deconvolution approach in DSC‐MRI the blood volume is normally estimated by the integration over the contrast curve, normalized by the area of the AIF. This approach assumes that the contrast agent is confined to the intravascular space for the duration of the measurement, and thus the DSC approach has to date been mostly used in CNS applications where the intact blood--brain barrier prevents CA leakage. We used a similar approach to estimate tissue AUC, integrated over both 30 and 60 seconds, normalized to the area of the AIF. However, due to CA extravasation, this AUC does not reflect tissue blood volume alone but rather the combined volume of the intravascular and extravascular, extracellular volume fractions. This is reflected in our results by the correlation between both AUC~30~ and AUC~60~ and the extracellular, extravascular volume fraction *v* ~*e*~ and the negative correlation with the CA reflux constant *k* ~*ep*~. We did not correct for CA leakage in the DSC‐based perfusion analysis, since *BF* obtained from AIF deconvolution, to a first approximation, can be assumed to be independent of CA leakage.[27](#jmri26740-bib-0027){ref-type="ref"} Further, current kinetic model‐based leakage correction methods applied to blood volume estimates from normalized tissue response time integrals rely on identification of a reference area with no CA leakage effects.[28](#jmri26740-bib-0028){ref-type="ref"} These methods are thus not readily applicable to non‐CNS applications since nonleaky reference regions cannot be obtained.

From this, it is concluded that estimation of pure intravascular blood volume is challenging using both DCE‐ and DSC‐MRI outside the CNS, limiting the ability to show the expected correlation with IVIM‐derived perfusion fraction *f*.[26](#jmri26740-bib-0026){ref-type="ref"} We did, however, find a weak negative correlation between *f* and the rate constant *k* ~*ep*~, and between *f* × *D\** and *K* ^*trans*^, without being able to find a biological reasoning behind this result. Recently, Sun et al^22^ investigated the relationship between IVIM and DCE‐MRI in a comparable cohort of rectal cancer patients and found a positive correlation between *f* × *D\** and *K* ^*trans*^. Interestingly, they report an *f*‐value about half the value of our estimations (17.02 ± 8.37% vs. 33 ± 3.4%). Given that their investigations are with a superior diffusion sequence (3.0T and 16 b‐values), one would assume their estimate to be more accurate. However, Xu et al,[29](#jmri26740-bib-0029){ref-type="ref"} who also did IVIM‐analysis on 3.0T with 16 b‐values, reports an *f*‐value similar to ours (\>30%), and it is therefore not likely that the diffusion sequence we used is the source of disagreement. Parameters from the IVIM analysis should, at least in theory, be more comparable between centers than for instance parameters from DCE‐ and DSC‐MRI, and the repeatability and conformance of these parameters are of great interest and importance when comparing studies. It is therefore interesting, but not easily addressed, whether these differences could be attributed to the imaging performance or the algorithms used for analyzing the data.

We used the same AIF for analysis of the DSC and the DCE data, without adjusting for the different AIF amplitude of the R~2~\*‐response compared with the R~1~‐response, as this will only have a linear and constant scaling effect on all parameters. Since the study was focused on parameter correlations between the different methods and not on absolute quantification, this scaling effect should not influence the results.

In a recent article,[30](#jmri26740-bib-0030){ref-type="ref"} Le Bihan mentions a common concern with the IVIM approach; the attenuation of the signal as it approaches higher b‐values results in the signal reaching the \"noise floor,\" where the signal is completely masked by the noise. We therefore checked our results by doing the curve fitting to the biexponential curve both with and without the highest b = 1300 s/mm^2^ value, which only resulted in linear shifts in the absolute value for all parameters and suggested that the curve fitting was adequately robust.

Our results would have been strengthened by the inclusion of a gold standard for perfusion measurements. There is, however, at present no clear gold standard for this purpose outside the CNS, and for this reason both DCE‐, DSC‐, and IVIM‐MRI are proposed as methods for obtaining hemodynamic parameters that reflect perfusion. All these methods have limitations. Perfusion and volume estimates by DSC‐MRI may be particularly challenging outside the CNS due to both kinetic model limitations (CA extravasation), uncertainty in AIF detection, and technical challenges relating to susceptibility artifacts and motion. Dynamic MRI acquisitions are particularly challenging in the pelvic cavity region due to susceptibility artifacts from gas‐pockets and bowel motion; in addition, large susceptibility effects can occur when the contrast agent accumulates in the bladder. Bowel motion and susceptibility artifacts from gas‐pockets are also a concern with DWI for the IVIM approach. Motion and susceptibility artifacts made it difficult to coregister smaller tumor volumes than 5 cm^3^, and they were excluded. We also experienced timing issues with the contrast administration after a software update, since this multiecho sequence was taken as part of a split dynamics sequence, interleaved with high spatial resolution images.[31](#jmri26740-bib-0031){ref-type="ref"} However, by focusing on comparing these models against each other and finding a moderate correlation regardless of the limitations and uncertainties in these estimations, the hypothesis that both these methods can be used for perfusion imaging in rectal tumors is strengthened. We have further shown that by acquiring multiecho contrast‐based MRI data, two separate dynamic series can be generated reflecting different contrast mechanisms and possibly different underlying hemodynamic tissue properties.

As this was a single‐center study, no comparison of parameters between imaging modalities from different vendors or with different field strength could be done. The patient population was heterogeneous, comprised of patients from many stages of rectal cancer, and so the underlying biology of the tumors may differ, and the biological interpretation of the measured parameters may vary within the patient population. However, this heterogeneity also ensures that the patient population is representative of the average rectal cancer patient in the clinic.

In conclusion, in rectal tumors, we observed a linear correlation between *D\** from IVIM imaging and *BF* obtained from the R~2~\*‐curve. In addition, we found several other correlations between parameters derived from DSC‐MRI, DCE‐MRI, and IVIM. However, the interpretation of these parameters may depend on the underlying biology, the choice of kinetic models, and the MRI acquisition protocols used. The observed negative correlation between the contrast agent transfer constant, *K* ^*trans*^, from DCE‐MRI and mean vessel size from IHC supports a dependence of *K* ^*trans*^ on mean tumor vessel surface area.
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